Studies have demonstrated that IL-7 not only promotes Th17 cell proliferation to enhance anti-tumour efficacy in a mouse B16F10 tumour model [69] but also is necessary for developing effector Th17 cells into resident memory T cells [70,71]. This evidence concerns the gene IL7 and neoplasm.